美股A股
StockGist
Back
8-K/A2026-04-09· qwen-plus

BYND · Beyond Meat, Inc.

0001655210-26-000027

SEC filing

Summary

Beyond Meat reported a $133.6 million operating loss and $61.6 million in Q4 2025 revenue, down 19.7% year-over-year, driven by weak category demand, SKU rationalization, cessation of China operations, and $106.6 million in one-time charges including a $548.7 million non-cash gain on debt restructuring that yielded $409.0 million net income.

Key takeaways

Full analysis

Beyond Meat’s Q4 2025 results reflect severe operational contraction and heavy restructuring activity. Revenue declined 19.7% YoY to $61.6 million, with volume down 22.4% across all channels—driven by weak plant-based meat category demand, reduced QSR chicken and burger sales, and distribution losses in U.S. retail and EU/Canada markets. Gross margin collapsed to 2.3% from 13.1%, burdened by $2.4 million in excess inventory charges from SKU rationalization and $1.5 million in China cessation costs, alongside higher materials costs and inventory provisions. Operating loss ballooned to $133.6 million (−217.0% margin), fueled by $49.0 million in asset write-downs, $38.9 million in litigation accruals, and $13.3 million in share-based compensation tied to the convertible debt exchange. Critically, the $409.0 million net income was entirely attributable to a $548.7 million non-cash gain on debt restructuring—masking an underlying $139.7 million pre-restructuring loss. Adjusted EBITDA loss widened sharply to $69.9 million (−113.5% of revenue), underscoring persistent margin erosion. Management acknowledged ongoing headwinds but emphasized structural improvements: reduced leverage, extended debt maturities, added liquidity, and a strategic rebrand to 'Beyond The Plant Protein Company™' to broaden into adjacent categories. While no forward guidance is disclosed, the commentary signals intent to stabilize revenue and expand margins—not through near-term growth, but via cost discipline, portfolio pruning, and brand evolution. Investors must assess whether these balance sheet and strategic adjustments can offset entrenched demand weakness and execution risk in new categories.